-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, the study was designed to investigate mild to moderate stroke, the prevalence of depression and the longitudinal course of the first year after the change
.
Researchers identified patients with mild to moderate ischemic stroke or cerebral hemorrhage (National Institutes of Health Stroke Scale score <16) and had at least one depression assessment at 3, 6 or 12 months after the stroke (N=648, 542, and 533, respectively)
.
Potential transformation analysis was used to evaluate the characteristics of depression symptoms measured by 8 patient health questionnaires during the period 3 to 12 months after stroke
The average age of the study participants was 65.
6 years, 49.
4% were women, and 56.
7% were Mexican Americans
.
The prevalence of post-stroke depression was 35.
Prevalence of depressive symptoms at 3, 6 and 12 months after stroke
The researchers identified subgroups with different patterns of depression symptoms, including mild/asymptomatic, major sleep disorders and fatigue symptoms, affective symptoms, and severe/all symptoms
.
Most participants with mild/asymptomatic symptoms persisted over time
The study observed the dynamic changes of post-stroke depression symptoms, indicating that in patients with mild to moderate stroke, post-stroke depression often persists after 6 months and should be continuously monitored and appropriately managed
